Collections

Business on the Front Lines

News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).

Quest to Offer Employers Virus Tests to Help in Return to Work - Bloomberg

Quest to Offer Employers Virus Tests to Help in Return to Work

By: Emma Court
Source: Bloomberg
Date of Publication: May 27th, 2020
Quest Diagnostics Inc. is offering services to large employers geared at getting their employees back to work safely, including testing for the novel coronavirus, analytics to monitor symptoms and hotspots, and services like temperature monitoring, the company announced Wednesday.
Exclusive_ Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist

Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist

By: Carl O'Donnell and Michael Erman
Source: Reuters
Date of Publication: June 10th, 2020
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
BIO_ Moderna, Merck execs see possible speed bumps in COVID-19 vaccine manufacturing _ FiercePharma

BIO: Moderna, Merck execs see possible speed bumps in COVID-19 vaccine manufacturing

By: Eric Sagonowsky
Source: FiercePharma
Date of Publication: June 11th, 2020
The companies will have to overcome many obstacles to quickly produce a COVID-19 vaccine.
ANIMAX DESIGNS TO PRODUCE FACE SHIELDS AND MASKS IN FIGHT AGAINST COVID-19 — Animax Designs

ANIMAX DESIGNS TO PRODUCE FACE SHIELDS AND MASKS IN FIGHT AGAINST COVID-19

Source: Animax Designs
Date of Publication: April 2nd, 2020
Animax Designs has swapped the production of animatronics with face shields to fight COVID-19.
U.S. EPA orders Amazon, eBay to stop selling unsafe COVID-19 products: Bloomberg

U.S. EPA orders Amazon, eBay to stop selling unsafe COVID-19 products: Bloomberg

Source: Reuters
Date of Publication: June 11th, 2020
E-commerce companies Amazon Inc and eBay Inc have been instructed by the U.S. Environmental Protection Agency (EPA) to stop selling unproven or unsafe disinfectants, including products falsely marketed as killing COVID-19, on their platforms, Bloomberg reported on Thursday.
J&J to begin human trials of COVID-19 vaccine in second half of July

J&J to begin human trials of COVID-19 vaccine in second half of July

By: Saumya Sibi Joseph
Source: Reuters
Date of Publication: June 10th, 2020
Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease.
Fast action creates 10,000 medical face shields in 23 days

Pivot toward protection, Fast action creates 10,000 medical face shields in 23 days

By: Raytheon
Source: Raytheon
Date of Publication: April 30th, 2020
On March 30, Raytheon Technologies CEO Greg Hayes made a promise to the nation. At the White House, he announced the company would deploy 3D printers and other technology to produce 10,000 medical face shields. That goal was reached in 23 days, and now Raytheon Technologies is aimed at more than doubling that production while the pandemic rages.
Facebook Details New Data for Good Initiatives Related to Covid-19_Adweek

Facebook Details New Data for Good Initiatives Related to Covid-19

By: David Cohen
Source: Adweek
Date of Publication: June 3rd, 2020
Facebook released new visualizations and datasets that are part of its Data for Good initiative, as well as a new survey related to Covid-19.
AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

By: Matthew Herper
Source: Stat News
Date of Publication: June 4th, 2020
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created by Oxford University, inking a series of deals with non-government organizations and another manufacturer.
Coronavirus: AstraZeneca to begin making potential vaccine

Coronavirus: AstraZeneca to begin making potential vaccine

Source: BBC News
Date of Publication: June 5th, 2020
Drug company AstraZeneca is to start producing a potential vaccine for coronavirus, its boss has told the BBC.

Browse Collections

  • The Changing Nature of Work COVID-19

    The Changing Nature of Work

    From virtual offices to essential workers, explore how companies are adapting to changes in the way we work.
    Read More
  • Business on the Front Lines COVID-19

    Business on the Front Lines

    News and perspectives from corporations rising to the challenge of the COVID-19 public health crisis.
    Read More
  • Leading in a Crisis COVID-19.

    Leading in a Crisis

    Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.
    Read More
  • Service and Community COVID-19

    Service and Community

    We’re in this together. Discover ways corporations are serving their communities and pivoting to become essential services.
    Read More